Letrobol
LETROBOL contains Letrozole 2.5 mg, an oral aromatase inhibitor used to lower estrogen levels. It is widely used in managing hormone-dependent breast cancer in postmenopausal women. This medication supports treatment progression, reduces recurrence risk, and may be part of a long-term therapeutic plan under medical supervision.
Uses
- Treatment of hormone-responsive breast cancer
- Reduces estrogen production in the body
- Used after initial cancer treatment to prevent recurrence
- Sometimes prescribed before surgery to shrink tumors for operability
- May be used in selected fertility-related treatments under specialist care
Information
Side effects
- Hot flashes/sweating
- Fatigue or dizziness
- Headache and joint pain
- Nausea or digestive discomfort
- Bone thinning with long-term use
Warning
- Prescription-only medication
- Not recommended for premenopausal women unless clinically justified
- Avoid use during pregnancy or breastfeeding
- Regular monitoring of bone density may be required
- Inform your doctor about all medicines being taken
- Keep out of reach of children
Storage
- Store at room temperature below 25°C
- Keep in a dry place away from moisture and sunlight
- Retain tablets in original packaging until consumption
Dose and Administration
- Administer orally, once daily with or without food
- Dosage should only be determined by a qualified doctor
- Treatment duration varies depending on response and medical evaluation
- Do not increase or skip doses without medical advice
Disclaimer: Consult with a healthcare professional before starting any new supplement or training program, especially anabolic steroids, to ensure they are appropriate for you.
